Document Detail

Herpes virus infections occur frequently following treatment with fludarabine: results of a prospective natural history study.
MedLine Citation:
PMID:  10233419     Owner:  NLM     Status:  MEDLINE    
We performed a prospective infectious natural history study of 21 patients with low-grade lymphoproliferative disorders receiving fludarabine as initial (n = 5) or salvage (n = 16) therapy. 12 (57%) of these patients developed herpes zoster (n = 9), herpes simplex I (n = 1) or herpes simplex II (n = 2) infections at a median of 8 (range 1-17) months following initiation of fludarabine, with 75% of these having completed therapy. All patients with herpes zoster developed severe post-herpetic neuralgia. Factors differentiating patients developing these infections included older age and low serum IgG or IgA. Based upon these prospective data, we conclude that herpes virus infections frequently occur following fludarabine treatment, necessitating aggressive patient education and new prophylactic strategies.
J C Byrd; L H McGrail; D R Hospenthal; R S Howard; N A Dow; L F Diehl
Related Documents :
11494159 - Ferrets as a transmission model for influenza: sequence changes in ha1 of type a (h3n2)...
9758349 - Acyclovir-resistant herpes simplex virus infections in a bone marrow transplant populat...
11693509 - Multiple sclerosis and varicella zoster virus infection: a review.
2827469 - Herpes simplex virus infection of the hand. a profile of 79 cases.
17635649 - Genital co-infection with herpes simplex viruses type 1 and 2: comparison of real-time ...
2751279 - Comparison of intramuscular recombinant alpha interferon (rifn-2a) with topical acyclov...
21867859 - Outpatient management of community-associated methicillin-resistant staphylococcus aure...
21906319 - Monitoring specific antibody responses against the hydrophilic domain of the 23 kda mem...
23422409 - A quorum-sensing-induced bacteriophage defense mechanism.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  British journal of haematology     Volume:  105     ISSN:  0007-1048     ISO Abbreviation:  Br. J. Haematol.     Publication Date:  1999 May 
Date Detail:
Created Date:  1999-06-24     Completed Date:  1999-06-24     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0372544     Medline TA:  Br J Haematol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  445-7     Citation Subset:  IM    
Hematology-Oncology Service, Divison of Hematologic Malignancies, Johns Hopkins Oncology Center, Baltimore, Maryland, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Herpesviridae Infections / chemically induced*,  complications
Immunosuppressive Agents / adverse effects*
Lymphoproliferative Disorders / complications,  drug therapy*
Middle Aged
Opportunistic Infections / complications*
Prospective Studies
Vidarabine / adverse effects,  analogs & derivatives*
Reg. No./Substance:
0/Immunosuppressive Agents; 21679-14-1/fludarabine; 5536-17-4/Vidarabine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Human myeloma cells express the CD38 ligand CD31.
Next Document:  Clofibric acid: a potential therapeutic agent in AML and MDS.